Literature DB >> 3840827

Chlamydia trachomatis: its role in tubal infertility.

R C Brunham, I W Maclean, B Binns, R W Peeling.   

Abstract

We compared the prevalence of antibody to Chlamydia trachomatis among 88 women undergoing an evaluation for infertility and 49 women attending an antenatal clinic. Demographic data regarding sexual behavior were also collected. Eighteen women had tubal infertility and 70 had infertility due to a variety of other reasons. In comparison with women who had other causes for infertility, women with tubal infertility began coitus sooner (17.7 +/- 2.2 years vs. 19.5 +/- 3.4 years, P less than .05) and had more lifetime sex partners (4.5 vs. 1.33, P less than .001). Women with tubal infertility had a higher prevalence of antibody to C. trachomatis (13 of 18) than did women with nontubal causes for infertility (6 of 70, P less than .0001) or pregnant women (11 of 49, P = .0003). This high prevalence of antibody to C. trachomatis among women with tubal infertility was independent of sexual experience. By immunoblot analysis, an antigen of approximately 57,000 Da was immunodominant in 11 of 13 seropositive subjects with tubal infertility vs. 2 of 6 seropositive subjects with nontubal infertility (P = .046) and 1 of 11 seropositive pregnant women (P = .0003). Thus, women with tubal infertility frequently have serological evidence of prior infection with C. trachomatis and have a distinctive antigen-specific humoral immune response. These results further support the etiologic role of infection with C. trachomatis in tubal infertility.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3840827     DOI: 10.1093/infdis/152.6.1275

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  76 in total

Review 1.  Vaginal douching: evidence for risks or benefits to women's health.

Authors:  Jenny L Martino; Sten H Vermund
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

2.  Chlamydia trachomatis heat shock proteins 60 and 10 induce apoptosis in endocervical epithelial cells.

Authors:  Rajneesh Jha; Harsh Vardhan; Sylvette Bas; Sudha Salhan; Aruna Mittal
Journal:  Inflamm Res       Date:  2010-08-05       Impact factor: 4.575

3.  Using STD electronic medical record data to drive public health program decisions in New York City.

Authors:  Rachel Paneth-Pollak; Julia A Schillinger; Jessica M Borrelli; Shoshanna Handel; Preeti Pathela; And Susan Blank
Journal:  Am J Public Health       Date:  2010-02-18       Impact factor: 9.308

4.  Isolation of a gene encoding a Chlamydia sp. strain TWAR protein that is recognized during infection of humans.

Authors:  L A Campbell; C C Kuo; R W Thissen; J T Grayston
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

5.  Differential effects of gamma interferon on Chlamydia trachomatis growth in polarized and nonpolarized human epithelial cells in culture.

Authors:  C D Kane; G I Byrne
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract.

Authors:  Xin Sun; Qi Tian; Luying Wang; Min Xue; Guangming Zhong
Journal:  Microbes Infect       Date:  2017-08-31       Impact factor: 2.700

7.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  One-day detection of PCR amplified Chlamydia trachomatis DNA in clinical samples: ELISA versus Southern blot hybridisation.

Authors:  R T Roymans; G Onland; B H Postma
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

9.  Fallopian tube obstruction as a sequela to Chlamydia trachomatis infection.

Authors:  M Kosseim; R C Brunham
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

10.  Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.

Authors:  M Kosseim; A Ronald; F A Plummer; L D'Costa; R C Brunham
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.